Delivery Order SPE2DB24D1205-SPE2DB25FCRAR
Award Date
10/23/24
Potential Completion Date
11/14/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 firm fixed price delivery order is for the supply of Zeposia 0.92 MG Capsule 30S, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Zeposia 0.92 mg capsules, valued at $8,933.14. This is a firm fixed-price delivery order contract with an ultimate completion date of August 23, 2024. The award does not utilize a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This federal contract award, valued at $4,466.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zeposia 0.92 MG capsules, a prescription medication, with a completion date of November 8, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a Set-Aside contract. The contract is a child order...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication, with a completion date of November 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Zeposia 0.92 MG Capsule 30S to the Defense Logistics Agency (DLA). The $22,332.85 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $4,466.57, is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.68 firm-fixed-price delivery order is for the drug Zeposia 0.92 MG Capsule 30s, with a performance period ending on August 31, 2023. The award is not associated with a set-aside program and appears to be part of AmerisourceBergen's broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Zeposia 0.92 mg capsules in a 30-count package to the Defense Logistics Agency (DLA), a defense agency. The $17,866.28 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,077,251 units of the medication ZEPOSIA 0.92 MG CAPSULE 30S. The firm-fixed-price delivery order, valued at $13,399.71, has an ultimate completion date of November 1, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, through its Corporate Office Division, has been awarded multiple federal...
This federal contract award, valued at $13,399.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 14, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...